Literature DB >> 18673339

Transplacental infection and apparently immunotolerance induced by a wild-type bluetongue virus serotype 8 natural infection.

K De Clercq1, I De Leeuw, B Verheyden, E Vandemeulebroucke, T Vanbinst, C Herr, E Méroc, G Bertels, N Steurbaut, C Miry, K De Bleecker, G Maquet, J Bughin, M Saulmont, M Lebrun, B Sustronck, R De Deken, J Hooyberghs, P Houdart, M Raemaekers, K Mintiens, P Kerkhofs, N Goris, F Vandenbussche.   

Abstract

Until recently, bluetongue (BT) virus (BTV) serotypes reportedly causing transplacental infections were all ascribed to the use of modified live virus strains. During the 2007 BT epidemic in Belgium, a significant increase in the incidence of abortions was reported. A study including 1348 foetuses, newborns and young animals with or without suspicion of BTV infection, was conducted to investigate the occurrence of natural transplacental infection caused by wild-type BTV-8 and to check the immunocompetence of newborns. BTV RNA was present in 41% and 18.5% of aborted foetuses from dams with or without suspected BTV involvement during pregnancy, respectively. The results of dam/calf pairs sampled before colostrum uptake provide evidence of almost 10% transplacental BTV infection in newborns. Apparently immunotolerant calves were found at a level of 2.4%. The current study concludes that the combined serological and real-time PCR (RT-qPCR) result of pregnant dams gives no indication of the infection status of the offspring except in the case of a double negative result. In a group of 109 calves with clinical suspicion of BT, born during the vector-free period, 11% were found to be RT-qPCR positive. The true prevalence was estimated to be 2.3%, indicating the extent of transplacental infection in a group of 733 calves of one to 4 months of age without BT suspicion. Moreover, virus isolation was successful for two newborn calves, emphasizing the need for restricting trade to BT-free regions of pregnant dams possibly infected during gestation, even if they are BTV RT-qPCR negative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673339     DOI: 10.1111/j.1865-1682.2008.01044.x

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  21 in total

Review 1.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

2.  The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination.

Authors:  Camille Szmaragd; Anthony J Wilson; Simon Carpenter; James L N Wood; Philip S Mellor; Simon Gubbins
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

Review 3.  Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases.

Authors:  N James Maclachlan; Alan J Guthrie
Journal:  Vet Res       Date:  2010-01-27       Impact factor: 3.683

4.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

5.  Determinants of bluetongue virus virulence in murine models of disease.

Authors:  Marco Caporale; Rachael Wash; Attilio Pini; Giovanni Savini; Paola Franchi; Matthew Golder; Janet Patterson-Kane; Peter Mertens; Luigina Di Gialleonardo; Gisella Armillotta; Rossella Lelli; Paul Kellam; Massimo Palmarini
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

6.  How much can diptera-borne viruses persist over unfavourable seasons?

Authors:  Maud V P Charron; Thomas Balenghien; Henri Seegers; Michel Langlais; Pauline Ezanno
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

7.  Quantitative assessment of the probability of bluetongue virus overwintering by horizontal transmission: application to Germany.

Authors:  Sebastian Napp; Simon Gubbins; Paolo Calistri; Alberto Allepuz; Anna Alba; Ignacio García-Bocanegra; Armando Giovannini; Jordi Casal
Journal:  Vet Res       Date:  2011-01-11       Impact factor: 3.683

8.  Susceptibility of in vitro produced hatched bovine blastocysts to infection with bluetongue virus serotype 8.

Authors:  Leen Vandaele; Wendy Wesselingh; Kris De Clercq; Ilse De Leeuw; Herman Favoreel; Ann Van Soom; Hans Nauwynck
Journal:  Vet Res       Date:  2011-01-24       Impact factor: 3.683

Review 9.  Virus-induced congenital malformations in cattle.

Authors:  Jørgen S Agerholm; Marion Hewicker-Trautwein; Klaas Peperkamp; Peter A Windsor
Journal:  Acta Vet Scand       Date:  2015-09-24       Impact factor: 1.695

10.  Transplacental transmission of bluetongue virus 8 in cattle, UK.

Authors:  Karin E Darpel; Carrie A Batten; Eva Veronesi; Susanna Williamson; Peter Anderson; Mike Dennison; Stuart Clifford; Ciaran Smith; Lucy Philips; Cornelia Bidewell; Katarzyna Bachanek-Bankowska; Anna Sanders; Abid Bin-Tarif; Anthony J Wilson; Simon Gubbins; Peter P C Mertens; Chris A Oura; Philip S Mellor
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.